Provided by Tiger Trade Technology Pte. Ltd.

Regeneron Pharmaceuticals

656.01
+4.100.63%
Post-market: 656.010.00000.00%19:34 EDT
Volume:708.39K
Turnover:467.40M
Market Cap:69.35B
PE:15.98
High:667.50
Open:658.29
Low:654.05
Close:651.91
52wk High:821.11
52wk Low:541.00
Shares:105.72M
Float Shares:103.30M
Volume Ratio:0.93
T/O Rate:0.69%
Dividend:3.59
Dividend Rate:0.55%
EPS(TTM):41.06
EPS(LYR):41.48
ROE:14.55%
ROA:6.13%
PB:2.21
PE(LYR):15.82

Loading ...

Earning Preview: Regeneron Pharmaceuticals—this quarter’s revenue is expected to increase by 16.16%, and institutional views are predominantly bullish

Earnings Agent
·
Jul 24

The Scientist with 1,000 Patents Fueling a Drug Powerhouse

Dow Jones
·
Yesterday

Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Jul 23

Movement Alert|Regeneron Pharmaceuticals Falls 3.28% in Regular Trading, Multiple Investment Banks Cut Target Prices Amid Earnings Warning

Market Focus
·
Jul 23

What Bundibugyo Ebola Vaccines and Treatments are Under Development

Reuters
·
Jul 22

Regeneron (REGN) Receives a Buy from Goldman Sachs

TIPRANKS
·
Jul 22

Analysts Are Bullish on These Healthcare Stocks: Valneva (VALN), Regeneron (REGN)

TIPRANKS
·
Jul 22

Regeneron’s POTS Study Wraps Up: What REGN7544 Could Mean for REGN Investors

TIPRANKS
·
Jul 22

Cantor Fitzgerald Adjusts Price Target on Regeneron Pharmaceuticals to $750 From $785

MT Newswires Live
·
Jul 22

Regeneron Pharma is Maintained at Buy by Guggenheim

Dow Jones
·
Jul 21

Telix Expects Fy2026 Revenue and Other Income Above US$1 Billion, Tracks Upper End of Guidance Range

Reuters
·
Jul 21

Goldman Sachs Adjusts Price Target on Regeneron Pharmaceuticals to $965 From $968, Maintains Buy Rating

MT Newswires Live
·
Jul 20

Biohaven enters into clinical supply agreement with Regeneron

TIPRANKS
·
Jul 20

Biohaven Signs Regeneron Supply Deal to Test Bhv-1530 with Libtayo

Reuters
·
Jul 20

Merck Gets US FDA Nod for First-in-its-class Oral Cholesterol Drug

Reuters
·
Jul 16

Movement Alert|Regeneron Pharmaceuticals Falls 3.2% in Pre-Market Trading, Multiple Banks Cut Target Prices Amid Q2 Earnings Warning

Market Focus
·
Jul 16

Booking, Alphabet, and 7 Other Stocks to Buy Ahead of Earnings

Dow Jones
·
Jul 16

Regeneron’s dupilumab granted orphan drug designation

TIPRANKS
·
Jul 15

Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 15

These Biggest and "Least Loved" Stocks Are the Ones to Pick Ahead of Earnings

Dow Jones
·
Jul 13